前往化源商城

N-(5-chloro-2-methoxyphenyl)-2-(1-(3,4-dimethylphenyl)-4-oxo-1H-pyrazolo[3,4-d]pyrimidin-5(4H)-yl)acetamide

更新时间：2025-08-25 16:17:00

N-(5-chloro-2-methoxyphenyl)-2-(1-(3,4-dimethylphenyl)-4-oxo-1H-pyrazolo[3,4-d]pyrimidin-5(4H)-yl)acetamide结构式
N-(5-chloro-2-methoxyphenyl)-2-(1-(3,4-dimethylphenyl)-4-oxo-1H-pyrazolo[3,4-d]pyrimidin-5(4H)-yl)acetamide结构式
委托求购 		常用名 N-(5-chloro-2-methoxyphenyl)-2-(1-(3,4-dimethylphenyl)-4-oxo-1H-pyrazolo[3,4-d]pyrimidin-5(4H)-yl)acetamide 英文名 N-(5-chloro-2-methoxyphenyl)-2-(1-(3,4-dimethylphenyl)-4-oxo-1H-pyrazolo[3,4-d]pyrimidin-5(4H)-yl)acetamide
CAS号 852451-41-3 分子量 437.9
密度 N/A 沸点 N/A
分子式 C22H20ClN5O3 熔点 N/A
MSDS N/A 闪点 N/A

 名称

英文名 N-(5-chloro-2-methoxyphenyl)-2-(1-(3,4-dimethylphenyl)-4-oxo-1H-pyrazolo[3,4-d]pyrimidin-5(4H)-yl)acetamide

 物理化学性质

分子式 C22H20ClN5O3
分子量 437.9
InChIKey NSCFDGBKZOHUML-UHFFFAOYSA-N
SMILES COc1ccc(Cl)cc1NC(=O)Cn1cnc2c(cnn2-c2ccc(C)c(C)c2)c1=O

 靶点实验

查看更多实验

实验名称：Cell-based high throughput primary assay to identify activators of GPR151
来源：The Scripps Research Institute Molecular Screening Center
靶标：RecName: Full=G-protein coupled receptor 151; AltName: Full=G-protein coupled receptor PGR7; AltName: Full=GPCR-2037; AltName: Full=Galanin receptor 4; AltName: Full=Galanin-receptor-like protein; Short=GalRL
External Id：GPR151_PHUNTER_AG_LUMI_1536_1X%ACT
实验名称：AlphaScreen-based biochemical high throughput primary assay to identify activators of...
来源：The Scripps Research Institute Molecular Screening Center
靶标：N/A
External Id：FBW7_ACT_ALPHA_1536_1X%ACT PRUN
实验名称：AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of...
来源：The Scripps Research Institute Molecular Screening Center
External Id：MITF_INH_Alpha_1536_1X%INH PRUN
共3条，当前第1页，共1页
1
本网页内容来自不同专业数据源，如对内容有疑义，欢迎联系service1@chemsrc.com。
品牌现货直购
我想出现在这里：
QQ交流
351666998 复制
QQ交流二维码
微信交流
133 1186 9306 复制
微信交流二维码

暂无推荐供应商。我要出现这里

相关化合物： 更多...
Cuprate(3-), (mu-(7-((4'-((8-(acetylamino)-1-(hydroxy-kappaO)-3-sulfo-2-naphthalenyl)azo-kappaN1)-3,3'-di(hydroxy-kappaO)(1,1'-biphenyl)-4-yl)azo-kappaN1)-8-(hydroxy-kappaO)-1,6-naphthalenedisulfonato(7-)))di-, trisodium
75268-77-8
Cuprate(3-), [2-[2-[[2-[2-(hydroxy-kappaO)-3-sulfo-5-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl-kappaN2]phenylmethyl]diazenyl-kappaN1]-5-sulfobenzoato(6-)-kappaO]-, hydrogen (1:3)
75173-67-0
Cuprate(4-), [mu-[5-(acetylamino)-3-[2-[3,3'-di(hydroxy-kappaO)-4'-[2-[1-(hydroxy-kappaO)-3,6-disulfo-2-naphthalenyl]diazenyl-kappaN1][1,1'-biphenyl]-4-yl]diazenyl-kappaN1]-4-(hydroxy-kappaO)-2,7-naphthalenedisulfonato(8-)]]-, sodium (1:4)
73297-26-4
Cuprate(4-), (mu-(4-amino-6-((3,3'-di(hydroxy-kappaO)-4'-((2-(hydroxy-kappaO)-3,6-disulfo-1-naphthalenyl)azo-kappaN1)(1,1'-biphenyl)-4-yl)azo-kappaN1)-5-(hydroxy-kappaO)-1,3-naphthalenedisulfonato(8-)))di-, tetrasodium
68140-35-2
Cuprate(4-), [mu-[[7,7'-[[6-(phenylamino)-1,3,5-triazine-2,4-diyl]diimino]bis[4-(hydroxy-kappaO)-3-[[2-(hydroxy-kappaO)-5-sulfophenyl]azo-kappaN1]-2-naphthalenesulfonato]](8-)]]di-, tetrasodium
80448-87-9
Cuprate(4-), [mu-[[6,6'-[[3,3'-di(hydroxy-kappaO)[1,1'-biphenyl]-4,4'-diyl]bis[(2,1-diazenediyl-kappaN1)[4,5-dihydro-3-methyl-5-(oxo-kappaO)-1H-pyrazole-4,1-diyl]]]bis[1,3-naphthalenedisulfonato]](8-)]]di-, hydrogen (1:4)
68239-45-2
Cuprate(4-), [mu-[[3,3'-[[3,3'-di(hydroxy-kappaO)[1,1'-biphenyl]-4,4'-diyl]bis(2,1-diazenediyl-kappaN1)]bis[5-amino-4-(hydroxy-kappaO)-2,7-naphthalenedisulfonato]](8-)]]tetrakis[2,2'-(imino-kappaN)bis[ethanol]]di-, hydrogen (1:4)
64567-64-2
Cuprate(4-), [mu-[[3,3'-[[3,3'-di(hydroxy-kappaO)[1,1'-biphenyl]-4,4'-diyl]bis(2,1-diazenediyl-kappaN1)]bis[5-amino-4-(hydroxy-kappaO)-2,7-naphthalenedisulfonato]](8-)]]bis[2,2'-(imino-kappaN)bis[ethanol-kappaO]]di-, lithium sodium (1:3:1)
74593-01-4
Cuprate(4-), [mu-[[3,3'-[[3,3'-di(hydroxy-kappaO)[1,1'-biphenyl]-4,4'-diyl]bis(2,1-diazenediyl-kappaN1)]bis[5-amino-4-(hydroxy-kappaO)-2,7-naphthalenedisulfonato]](8-)]]bis[2,2'-(imino-kappaN)bis[ethanol-kappaO]]di-, lithium sodium (1:2:2)
74593-00-3
Cuprate(4-), [mu-[[3,3'-[[3,3'-di(hydroxy-kappaO)[1,1'-biphenyl]-4,4'-diyl]bis(2,1-diazenediyl-kappaN1)]bis[5-amino-4-(hydroxy-kappaO)-2,7-naphthalenedisulfonato]](8-)]]bis[2,2'-(imino-kappaN)bis[ethanol-kappaO]]di-, lithium sodium (1:1:3)
74592-99-7
CAS号[852451-41-3]化源网提供[N-(5-chloro-2-methoxyphenyl)-2-(1-(3,4-dimethylphenyl)-4-oxo-1H-pyrazolo[3,4-d]pyrimidin-5(4H)-yl)acetamide]MSDS、说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。>>移动MIP版：N-(5-chloro-2-methoxyphenyl)-2-(1-(3,4-dimethylphenyl)-4-oxo-1H-pyrazolo[3,4-d]pyrimidin-5(4H)-yl)acetamide
标题：852451-41-3_CAS号:852451-41-3_N-(5-chloro-2-methoxyphenyl)-2-(1-(3,4-dimethylphenyl)-4-oxo-1H-pyrazolo[3,4-d]pyrimidin-5(4H)-yl)acetamide - 化源网 地址：https://m.chemsrc.com/cas/852451-41-3_2113931.html

首页 |  期刊大全 |  MSDS查询 |  化工产品分类 |  生物活性化合物 |  关于我们 |  免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2026 ChemSrc All Rights Reserved